Dr Michelle Tempest and Marc Kitten, both Partners at healthcare and life sciences consultancy Candesic, explore the excitement around Digital therapeutics (DTx) as an emerging field in healthcare. DTx use technology to deliver evidence-based interventions to treat, manage, or prevent diseases. This article examines the current state of DTx in Europe, its challenges and opportunities, and the implications for healthcare providers, policymakers, and investors.
Read the full article here.